Beardsell (BEARDSELL)
Slow GrowerScore breakdown: P/E: 3/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹24.72 |
| Market Cap | ₹97.49 Cr |
| P/E Ratio | 8.52 |
| ROCE | 15.56% |
| ROE | —% |
| Dividend Yield | 0.4% |
| Profit Growth | -21.17% |
| Debt/Equity | 0.24 |
| Sales Growth | 10.38% |
| Promoter Holding | 52.68% |
| 52-Week Range | ₹20.02 — ₹38.6 |
| Sector | Industrial Products |
| Book Value | ₹23.31 |
Strengths
- Low valuation: P/E of 11.23 and P/B of 1.18, close to book value of ₹21.79.
- Conservative balance sheet with debt-to-equity of only 0.36.
- ROCE of 15.56% suggests decent capital efficiency.
- Promoter holding of 52.68% aligns management with minority shareholders.
Concerns
- Profit growth is down 16.67%, and latest quarter net margin is thin at roughly 3% (₹2 Cr profit on ₹67 Cr sales).
- Piotroski F-Score of 4/9 indicates weak overall financial health.
- Sales growth of just 2.78% with PEG of 4.04 points to very limited growth prospects.
- Dividend yield of 0.39% offers negligible income support while waiting.
AI Analysis
At ₹25.79, Beardsell is a small-cap industrial player with a market cap of only ₹100 crore. Graham would like the balance sheet: book value is ₹21.79, so I am paying just 1.18 times book, and debt-to-equity is a modest 0.36. ROCE of 15.56% shows capital is being deployed reasonably. But a business is worth more than its assets; it must earn well over time. Here the picture is less comforting. Sales grew only 2.78% and profits fell 16.67%. The latest quarter sales of ₹67 crore produced just ₹2 crore net profit—a thin margin. The Piotroski F-score of 4/9 is a warning flag: financial health is mediocre. A PEG ratio of 4.04, even with a low P/E, says the market expects very little growth, and at 0.39% dividend yield, I am not being paid to wait. The 52-week range of ₹20.02 to ₹38.60 shows the market itself is uncertain about its worth. The 52.68% promoter holding is encouraging, but I need to see management produce growth and protect margins. This is not a wonderful business at a fair price; it is a mediocre grower at a cheap price. Without a clear moat or strong earnings momentum, I cannot classify it as a stalwart. I would need either a much larger margin of safety or evidence of a genuine turnaround before acting. For now, it belongs on the watch-list, not in my portfolio.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer